Merck & Co. (NYSE: MRK) last traded at $152.55, up 2.39% on the session. The quote above updates while this page is open; the figures below are drawn from Merck & Co.’s own filings and are restated only when a new one is published.
Merck & Co. trades on NYSE under the ticker MRK. It is classified in the Healthcare sector, Pharmaceuticals industry. Its market capitalisation is $376.37 billion.
Healthcare sectorPharmaceuticalsListed on NYSE
Valuation measures for Merck & Co., derived from the latest quote and its most recent SEC filing.
| Market cap | $376.37B |
|---|---|
| P/E ratio | 122.04 |
| Price / sales | 5.65 |
| Price / book | 8.98 |
| Beta | 0.14 |
Trailing-twelve-month figures tagged in Merck & Co.'s XBRL filings with the SEC.
| Revenue (TTM) | $66.57B |
|---|---|
| Net income (TTM) | $3.17B |
| EPS (TTM) | $1.25 |
| Return on equity | 7.57% |
| Cash | $6.85B |
Range and volume for MRK over the past 52 weeks.
| 52-week high | $154.49 |
|---|---|
| 52-week low | $77.58 |
| Volume | 11.43M |
| Average volume | 10.86M |
| Previous close | $148.99 |
Dividend history for Merck & Co. over the trailing twelve months.
| Dividend yield | 2.20% |
|---|---|
| Dividend per share (TTM) | $3.36 |
| Payout ratio | 268.80% |
Other Healthcare companies tracked on FurlPay Markets.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.